Fernanda Kussi
YOU?
Author Swipe
View article: #1373 The role of uremic toxins and inflammation in eryptosis and renal anemia among dialysis patients
#1373 The role of uremic toxins and inflammation in eryptosis and renal anemia among dialysis patients Open
Background and Aims Elevated levels of uremic toxins (UT) and inflammatory cytokines have been implicated in increased eryptosis, a form of premature erythrocyte death, potentially contributing to renal anemia. This study explores the inte…
View article: Remodeling of Gut Microbial Networks After Sulforaphane Supplementation in Patients with Chronic Kidney Disease
Remodeling of Gut Microbial Networks After Sulforaphane Supplementation in Patients with Chronic Kidney Disease Open
Background and Objectives: Chronic kidney disease (CKD) is closely associated with gut dysbiosis, and sulforaphane (SFN), a bioactive compound found in cruciferous vegetables, may help to mitigate this condition. Methods: These are seconda…
View article: Apitherapy with Royal Jelly and Green Propolis EPP-AF® Improves Cardiovascular Risk Markers in Patients Undergoing Hemodialysis
Apitherapy with Royal Jelly and Green Propolis EPP-AF® Improves Cardiovascular Risk Markers in Patients Undergoing Hemodialysis Open
Background: Reducing cardiovascular risk markers is an essential target in chronic kidney disease (CKD). Thus, this study aimed to evaluate the effect of royal jelly plus green propolis supplementation on cardiovascular disease (CVD) risk …
View article: Bioactive Compounds as Modulators of N-Formyl Peptide Signaling in Chronic Diseases
Bioactive Compounds as Modulators of N-Formyl Peptide Signaling in Chronic Diseases Open
In physiological situations involving cell damage, molecules derived from mitochondria or bacteria are produced. These molecules are known as N-formyl peptides and are detected by formyl peptide receptors (FPRs), which stimulate immune cel…
View article: Effects of Propolis Supplementation on Gut Microbiota and Uremic Toxin Profiles of Patients Undergoing Hemodialysis
Effects of Propolis Supplementation on Gut Microbiota and Uremic Toxin Profiles of Patients Undergoing Hemodialysis Open
Background: Propolis possesses many bioactive compounds that could modulate the gut microbiota and reduce the production of uremic toxins in patients with chronic kidney disease (CKD) undergoing hemodialysis (HD). This clinical trial aimed…
View article: Uremic toxins, inflammation biomarkers and hepcidin in older CKD patients switched from high flux HD to OL-HDF
Uremic toxins, inflammation biomarkers and hepcidin in older CKD patients switched from high flux HD to OL-HDF Open
Anemia is a common complication that is associated with mortality in patients with chronic kidney disease (CKD). Despite the use of erythropoiesis-stimulating agents (ESAs) to correct anemia, some patients are hyporesponsive due to the sta…
View article: Older Patients on Hemodiafiltration: Behavior of Uremic Toxins, Inflammation, Endothelium, and Bone Mineral Disorder
Older Patients on Hemodiafiltration: Behavior of Uremic Toxins, Inflammation, Endothelium, and Bone Mineral Disorder Open
Chronic kidney disease (CKD) affects 10% of the world’s population. Uremic toxins, such as indoxyl sulfate (IS), p-Cresylsulfate (PCS) and indole acetic acid (IAA), are not sufficiently removed by conventional hemodialysis (HD) and have be…